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OBJECTIVES This study examined gender differences and temporal changes in the clinical characteristics of
patients referred for nuclear stress imaging, their imaging results and subsequent utilization
of coronary angiography and revascularization.
BACKGROUND Gender bias may influence resource utilization in patients with coronary artery disease
(CAD). No study has analyzed gender differences and time trends in patients referred for
noninvasive testing and subsequent use of invasive procedures.
METHODS Between January 1986 and December 1995, 14,499 patients (5,910 women and 8,589 men)
without established CAD underwent stress myocardial perfusion imaging. The clinical
characteristics, imaging results, coronary angiograms and revascularization outcomes were
compared in women and men over time.
RESULTS The mean pretest probability of CAD was lower in women (45%) than in men (70%) (p ,
0.001). More women (69%) than men (42%) had normal nuclear images (p , 0.001). Men
(17%) were more likely than women (8%) to undergo coronary angiography (p , 0.001).
Male gender was independently associated with referral for coronary angiography (multivar-
iate model: chi-square 5 16, p , 0.001) but was considerably weaker than the imaging
variables (summed reversibility score: chi-square 5 273, p , 0.001). Revascularization was
performed in more men (46% of the population undergoing angiography) than women (39%)
(p 5 0.01), but gender was not independently associated with referral to revascularization.
There were no significant differences in clinical, imaging or invasive variables between the
genders over time.
CONCLUSIONS There was little evidence for a bias against women in this study. Women were somewhat less
likely to undergo coronary angiography but were referred for stress perfusion imaging more
liberally. Practice patterns remained constant over this 10-year period. (J Am Coll Cardiol
2001;38:690–7) © 2001 by the American College of Cardiology
Studies designed to examine gender differences in patients
undergoing evaluation for coronary artery disease (CAD)
have been controversial. Resource use has been reported to
be lower (1–12) or no different (13–22) in women than in
men. A small number of studies have reported lower
utilization of only certain resources in women (23–27),
suggesting that gender bias might influence the clinical
decision-making process at different nodal points. Only two
studies have examined time trends in resource utilization
patterns (13,25). These studies focused on selected subsets
of patients with established CAD and examined their
resource use between the 1970s and 1980s. Since then,
many commentaries have been published addressing gender
bias (28–35). No study has examined gender differences and
time trends in a more recent cohort of patients referred for
stress testing with follow-up coronary revascularization.
This study was designed to examine whether there were
gender differences and temporal changes over the 10-year
period of 1986 to 1995 in: 1) the clinical characteristics of
the population referred for stress single-photon emission
computed tomography (SPECT); 2) the results of SPECT
imaging; 3) the SPECT findings associated with subsequent
referral to cardiac catheterization; and 4) the catheterization
findings associated with referral to revascularization.
METHODS
Study population. Imaging with SPECT was first utilized
at the Mayo Clinic in January 1986. Between January 1986
and December 1995, 36,504 thallium-201 (Tl-201) or
technetium-99m (Tc-99m) sestamibi imaging studies were
performed. Patients were excluded from these studies for
the following reasons (some patients had more than one
criterion): 1) established CAD on the basis of a history of
documented myocardial infarction (MI), previous coronary
artery bypass graft surgery (CABG) or previous percutane-
ous transluminal coronary angioplasty (PTCA) (n 5
17,436); 2) left bundle branch block or paced ventricular
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rhythm (n 5 2,587); 3) clinically significant valvular heart
disease (n 5 3,031); 4) rest study only (n 5 813); 5) stress
modality dobutamine infusion (n 5 539) or cycle ergometry
(n 5 13); and 6) refusal of research authorization (n 5 57).
Because this study was designed to focus on testing for
diagnostic purposes, patients with established CAD were
excluded. Patients with left bundle branch block, paced
ventricular rhythm or valvular heart disease were excluded,
because these entities have been associated with false-
positive perfusion studies (36–38). Because dobutamine or
cycle ergometry was used in relatively few patients who did
not qualify for more conventional forms of stress, these
patients were also excluded. Only the first study was
analyzed in patients with multiple studies (n 5 1,031). The
study population consisted of 14,499 patients. Baseline
clinical data were collected at the time of stress testing and
entered into a computer database. Chest pain was graded
according to the criteria of Diamond (39).
Stress SPECT imaging. This method has been described
previously (40–42). Patients underwent treadmill (n 5
10,898) or pharmacologic (n 5 3,601) SPECT imaging.
Treadmill testing was performed using the Bruce or Naugh-
ton protocol until standard end points were reached. Phar-
macologic stress testing was performed with intravenous
administration of adenosine (140 mg/kg per min over 6 min;
n 5 1,545) or dipyridamole (0.56 mg/kg for 4 min; n 5
2,056). The stress electrocardiogram was interpreted as
positive for ischemia if there was $1.0 mm horizontal or
downsloping ST segment depression 80 ms after the J point,
compared with baseline. The radioisotope was injected
during the last 60 to 90 s of exercise, at 3 min of the
adenosine infusion or 3 to 4 min after termination of the
dipyridamole infusion.
Thallium-201 imaging was performed as a one-day pro-
tocol. During stress, 3 to 4 mCi of Tl-201 were injected.
Imaging with SPECT began 10 to 15 min later by using the
“step-and-shoot” method. Delayed rest imaging was per-
formed 3 to 4 h later. Patients imaged after January 1, 1990
underwent re-injection with 1 mCi of Tl-201 before de-
layed imaging. Technetium-99m sestamibi was first used in
1991. Sestamibi imaging was generally performed as a
two-day protocol, with rest imaging on the first day and
stress imaging on the second day; 15 mCi of Tc-99m
sestamibi were injected during stress and 30 mCi at rest.
The same SPECT method for Tl-201 was used for Tc-99m
sestamibi, except that imaging started 45 to 60 min after the
sestamibi injection. The images were processed and recon-
structed using standard procedures (40–42).
The images were interpreted by consensus of two expe-
rienced observers. These observers were aware of each
patient’s gender. The stress and rest images were displayed
side by side in three planes (short-axis, horizontal long-axis
and vertical long-axis), divided into 24 segments. Uptake in
each segment was graded on a 5-point scale (0 5 absent
uptake; 1, 2 and 3 5 severely, moderately and mildly
diminished uptake, respectively; and 4 5 normal uptake).
For the purposes of this study, only the scoring in the 14
short-axis segments was used. Mild fixed defects (scores of
3 stress and 3 delayed) were considered normal, because
most of these defects are due to soft-tissue attenuation.
Summed stress and rest scores were calculated as the
summation of the uptake in each of the 14 short-axis
segments on the stress and rest images, respectively (43).
The summed stress score (SSS) for a normal image is 56
(14 3 4). The Cedars-Sinai laboratory has reported that
cut-points for SSS (an equivalent score #47 using our
scoring system) can identify high-risk patients (43). The
summed reversibility score (SRS) was calculated as the
difference between the summed rest and stress scores. A
nonischemic image has a score of 0. Left ventricular size was
assessed subjectively and coded as enlarged or not enlarged.
Coronary angiography. Coronary angiography was re-
ported if it occurred within three months after the stress
test. The angiographers were aware of each patient’s gender
and the results of SPECT imaging. The angiograms were
coded according to Coronary Artery Surgery Study criteria
($50% diameter narrowing of the left main coronary artery
or $70% diameter narrowing of the left anterior descend-
ing, left circumflex or right coronary artery or their major
branches was considered significant) (44).
Revascularization. Coronary angioplasty and CABG were
reported if they were performed within three months of
angiography. For patients with multiple procedures, only
the first procedure was counted.
Statistical analysis. The SAS software (Cary, North Caro-
lina) was used. Comparisons between men and women were
completed using the Wilcoxon rank-sum test for continuous
variables and the chi-square test (for independence) for
categorical variables. For symptomatic patients ,70 years
old, the pretest probability of CAD was estimated on the
basis of age, gender and chest pain type (no data are
provided for estimating the probability in asymptomatic
patients or those .70 years old) (45). Logistic regression
models were used to assess factors related to referral to
coronary angiography and revascularization (46). Multivar-
iate models to predict these end points were developed using
the stepwise selection technique. The entire study popula-
tion was analyzed for the angiographic model. The variables
considered included age, gender, symptom status, chest pain
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CAD 5 coronary artery disease
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary
angioplasty
SPECT 5 single-photon emission computed tomography
SRS 5 summed reversibility score
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Tc-99m 5 technetium-99m
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type, smoking history, hypertension (by history or repeated
blood pressure .140/90 mm Hg), hyperlipidemia (by his-
tory or cholesterol or triglyceride levels .90th percentile for
age and gender), diabetes (by history or repeated fasting
glucose levels .120 mg/dl), type of stress test (pharmaco-
logic or exercise), SSS, SRS and left ventricular enlarge-
ment. Only patients who underwent coronary angiography
were included in the revascularization model. The variables
considered for the revascularization model included the
same aforementioned variables and also the extent of CAD
on angiography. Differences between the genders over time
were investigated using a gender-time interaction term in
the logistic regression models. The C-index was used to
measure the classification ability of the models. Bootstrap-
ping was performed to confirm the stability of the estimates
in each model by running 1,000 samples, with replacement
of the 14,499 observations in the angiography data set and
the 1,905 observations in the revascularization data set, and
then running the logistic stepwise procedure on each of the
1,000 samples. The number of times each factor came into
the final model was tabulated. For all analyses, p , 0.05 was
considered significant.
RESULTS
Stress test patterns and patient characteristics. Overall,
5,910 women and 8,589 men underwent stress SPECT
(Table 1). At all time points, more men than women were
tested. The number of studies increased during the first five
years and remained relatively constant thereafter. More
women (30%) than men (21%) were imaged with Tc-99m
sestamibi (p , 0.001), reflecting our laboratory’s recom-
mendation to clinicians to use this agent in women in whom
a breast artifact on the images was anticipated. More
women (31%) than men (20%) underwent pharmacologic
stress testing (p , 0.001). Mean age was slightly higher in
women and remained constant throughout the study. More
women than men had symptoms of chest pain, but the
percentages of patients with typical angina were similar. A
minority of patients (10%) underwent evaluation of exer-
tional dyspnea. More men (33%) than women (17%) were
asymptomatic (p , 0.001). There was no change in symp-
tom status in either gender over time. The average calcu-
lated pretest probability of CAD in symptomatic patients
remained constant in both genders throughout the study
(Fig. 1). More men than women had a history of cigarette
smoking. More women than men were hypertensive or
hyperlipidemic. There was no difference between the gen-
ders for diabetes. The mean number of risk factors increased
slightly over time in women, from 1.5 between 1986 and
1990 to 1.6 between 1991 and 1995 (p , 0.001), and also
in men, from 1.6 between 1986 and 1990 to 1.7 between
1991 and 1995 (p , 0.001). The difference between the
genders was not significant. The consistency of age, symp-
tom status and risk factor profile indicates that there was no
important gender-related change in clinical characteristics
during the time course of this study.
Stress SPECT results. Abnormal scans were more com-
mon in men (58%) than in women (31%) (p , 0.001)
(Table 2). The percentage of normal studies over time
remained constant in women, but decreased slightly in men
(p 5 0.02). This difference between the genders was not
significant, however. The summed stress and reversibility
scores were also significantly worse in men. A “high-risk”
scan (SSS #47) was present in 1,942 men and 471 women.
The SSS remained constant over time in men, but decreased
slightly in women (p 5 0.03). In both genders, there were
also small but statistically significant increases in SRS over
time (p 5 0.003 for men; p , 0.001 for women).
Coronary angiography. More men (n 5 1,418; 17% of the
male study population) than women (n 5 487; 8% of the
female population) were referred for coronary angiography
(p , 0.001) (Fig. 2, Table 3). Over time, there was a slight
increase in the percentage of women, but not men, referred
(p 5 0.04). Although there was a significant difference
between men and women in the overall rate of referral to
angiography, this difference did not change significantly
Table 1. Clinical Characteristics
Year
No. of
Studies
Mean Age
(years)
Chest Pain
(%)
Typical
Angina
(%)
Smoking
History
(%)
Hypertension
(%)
Hyperlipidemia
(%)
Diabetes
(%)
Women Men Women Men Women Men Women Men Women Men Women Men Women Men Women Men
1986 59 112 60.2 58.9 75 54 19 20 56 70 44 45 37 28 8 10
1987 217 350 62.7 59.9 75 58 19 19 43 67 57 46 45 33 15 14
1988 381 665 61.1 59.3 77 55 19 16 36 65 51 47 44 39 14 13
1989 627 907 62.3 61.0 77 56 19 23 39 65 50 46 46 41 13 15
1990 634 1,000 62.2 61.3 76 63 20 23 34 63 52 46 44 36 17 13
1991 836 1,183 63.5 61.4 73 58 19 23 37 57 54 48 51 40 13 16
1992 826 1,137 62.9 61.5 73 58 19 20 39 62 53 46 55 44 17 14
1993 740 1,033 62.9 61.3 73 58 21 20 38 62 56 50 53 44 15 18
1994 791 1,058 64.2 61.7 68 53 19 20 38 59 56 49 54 48 18 19
1995 799 1,144 62.6 61.7 67 51 18 18 38 60 56 51 53 50 20 17
Mean value 591* 859 62.8* 61.2 73* 57 19† 20 38* 62 54* 48 50* 43 16† 16
*p , 0.001, women vs. men; †p 5 NS, women vs. men.
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over time (p 5 NS). In patients with a “high-risk” SSS,
46% of men and 51% of women were referred to angiogra-
phy. In the univariate analysis, all variables analyzed were
significantly associated with referral to angiography. In
the multivariate analysis, the nuclear imaging variables
were much more powerful than the clinical variables.
Gender was an independent but relatively weak predictor in
the multivariate model. There was no interaction
between gender and time in the multivariate model. On
angiography, more men (76%) than women (62%) had
significant CAD (p , 0.001). Triple-vessel CAD was also
more prevalent in men (25%) than in women (19%) (p 5
0.005). The percentages of patients with significant CAD
and the extent of CAD remained constant in both genders
over time.
Revascularization. Procedures were performed in 192
women (102 had PTCA and 90 had CABG) and 655 men
(268 had PTCA and 387 had CABG) (Fig. 3, Table 4) The
type of procedure was more likely to be PTCA in women and
CABG in men (p 5 0.003). Expressed as a percentage of the
patients who underwent angiography, 39% of women versus
46% of men were referred for revascularization (p 5 0.01). In
neither gender was there a significant change in the percent-
ages of patients referred for revascularization over time. Gender
was significantly associated with referral to revascularization in
the univariate analysis, but not in the multivariate analysis.
DISCUSSION
Many studies have addressed gender bias and resource
utilization in patients with CAD (1–27). The majority of
these studies have limited their analyses to the subset of
patients with acute MI referred for invasive procedures. The
“upstream” use of tests impacts the “downstream” use of
more invasive procedures (47,48). Therefore, this study was
designed to encompass patients presenting for noninvasive
stress testing and following them to revascularization to
address the possibility of gender bias at multiple steps in the
Table 2. Single-Photon Emission Computed Tomographic Results
Year
Normal Images
(%)
At Least One
Reversible
Segment (%) SSS* SRS†
Women Men Women Men Women Men Women Men
1986 86 60 14 37 54.8 52.9 1.0 1.6
1987 71 45 26 48 54.2 51.9 1.1 2.1
1988 72 45 27 50 54.3 51.2 1.0 2.7
1989 68 36 30 60 53.8 50.3 1.6 3.4
1990 70 40 28 55 53.8 50.6 1.5 3.5
1991 71 42 27 54 54.1 50.6 1.4 3.6
1992 68 42 30 54 53.8 50.9 1.5 3.4
1993 70 45 29 51 53.8 51.0 1.6 3.2
1994 65 42 33 52 53.7 51.1 1.7 3.1
1995 66 39 33 55 53.8 50.6 1.6 3.5
Mean value 69‡ 42 30‡ 54 53.9‡ 50.9 1.5‡ 3.3
*A summed stress score (SSS) of 56 represents a normal image; †a summed reversibility score (SRS) of 0 represents a
nonischemic image; ‡p , 0.001, women vs. men.
Figure 1. Mean pretest probability of coronary artery disease in females (squares) and males (circles) ,70 years old with symptoms of chest pain, plotted
over time.
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decision-making process. Women appear to have been
referred for stress SPECT imaging more frequently than
men, on the basis of their lower pretest probability of CAD
and higher percentage of normal SPECT images. The only
step in which women were less likely to be evaluated was
coronary angiography. Male gender was an independent
predictor of referral to angiography, but was considerably
weaker than the SPECT variables. Overall, there was little
evidence for a bias against women in this study. Analysis of
time trends indicated that practice patterns remained re-
markably constant. Several editorials on gender bias were
published during the 10-year study period (28–34). The
increasing attention directed to gender bias did not have an
impact on practice patterns.
The controversy of gender bias. In a meta-analysis exam-
ining patient outcomes after MI, Vaccarino et al. (49) noted
that the higher early crude mortality rates in women often
disappear after controlling for age and other factors. Simi-
larly, some studies have noted that the lower crude rates of
coronary angiography in women no longer persist after
adjustment for confounding variables or appropriateness of
its use (14,18,20,21,27). If gender bias does exist, it appears
to have more of an impact on the use of diagnostic testing
and administration of thrombolytic therapy (1,2,4–12,23–
26). Once coronary angiography is performed, most
(13,14,16,17,19,20,22–26), but not all (2,3,6,8,9,27), stud-
ies have found no gender difference in referral to revascu-
larization.
Time trends. Only two studies have examined gender
differences and time trends in patients with CAD. Bickell et
al. (13) studied referral to CABG for three periods: 1969 to
1974, 1975 to 1979 and 1980 to 1984. Although there was
no gender difference for the entire study population, among
low-risk patients, men were more likely to be referred
during the most recent period. Chiriboga et al. (25) exam-
ined utilization of several cardiac services in patients with
acute MI during six different years between 1975 and
1988. Over time, there was an increase in the use of
invasive procedures in both genders, with men more
likely to undergo coronary angiography and PTCA in the
Figure 2. Percentages of females (squares) and males (circles) referred for coronary angiography from the total study population, plotted by year.
Table 3. Referral to Coronary Angiography
Variable
Univariate Analysis Multivariate Analysis*
Chi-Square p Value OR (95% CI) Chi-Square p Value OR (95% CI)
SSS† (5-point decrease) 2,066 , 0.001 2.4 (2.3–2.5) 147 , 0.001 1.5 (1.4–1.6)
SRS‡ (1-point increase) 2,020 , 0.001 1.3 (1.29–1.32) 273 , 0.001 1.18 (1.17–1.20)
Cardiac enlargement 502 , 0.001 3.9 (3.3–4.3) — — —
Gender (male) 202 , 0.001 2.2 (2.0–2.5) 16 , 0.001 1.3 (1.1–1.5)
Chest pain class 62 , 0.001 1.2 (1.1–1.2) — — —
Diabetes 56 , 0.001 1.3 (1.2–1.4) — — —
Smoking 23 , 0.001 1.2 (1.1–1.3) 4 0.047 1.1 (1.0–1.2)
Symptom status 22 , 0.001 1.3 (1.2–1.5) 17 , 0.001 1.3 (1.2–1.5)
Pharmacologic stress 14 , 0.001 1.2 (1.1–1.4) 9 0.003 1.2 (1.1–1.4)
Age (10-year increase) 10 0.002 1.07 (1.03–1.11) 27 , 0.001 0.87 (0.82–0.91)
Hypertension 9 0.004 1.2 (1.1–1.3) — — —
Hyperlipidemia 5 0.034 1.1 (1.0–1.2) — — —
*Variables without numbers in the multivariate analysis did not meet the entry criteria into the final model; †a summed stress score (SSS) of 56 represents a normal image; ‡a
summed reversibility score (SRS) of 0 represents a nonischemic image. Final model: chi-square 5 3,051, p , 0.001, C-index 5 0.87. Bootstrapping analysis SSS and SRS came
into every model, symptom status in .99% of the models, gender in 97%, pharmacologic stress in 81% and age in 79%.
CI 5 confidence interval; OR 5 odds ratio.
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later years, but there was no gender difference in referral
to CABG.
Study limitations. This study has several limitations. First,
the cohort was comprised of patients referred for SPECT at
a tertiary-care center. This study cannot address whether
there was gender bias in more “upstream” decision-making
involving the entire population of patients presenting for
evaluation of CAD at our institution. In an earlier
population-based study of Olmsted County residents, we
reported that women were less likely than men to undergo
stress testing (10). Second, physicians were aware of each
patient’s gender when interpreting the test results, which
could have introduced bias in their reports. If such bias
existed, it did not change over time. Third, certain poten-
tially important variables, such as patient preference for a
specific treatment, socioeconomic status and left ventricular
ejection fraction, were either not collected or not collected
in a uniform fashion in the data base. Analysis of such
variables could alter the results of the statistical modeling.
Finally, no follow-up data were collected to determine
whether there was a gender difference in the patients’
outcome as a measure of the “correctness” of medical
decision-making.
Conclusions. The issue of gender bias in patients with
CAD remains controversial. In this study, there was little
evidence for lower utilization of diagnostic and therapeutic
services in women. Practice patterns remained constant,
despite increasing medical reports raising concern about
possible gender bias.
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Figure 3. Percentages of patients referred for revascularization from the angiographic population, plotted by year. The numbers at the top of the columns
represent the absolute number of revascularization procedures done each year. Solid bars 5 bypass surgery; stripped bars 5 percutaneous interventions.
Table 4. Referral to Revascularization
Variable
Univariate Analysis Multivariate Analysis*
Chi-Square p Value OR (95% CI) Chi-Square p Value OR (95% CI)
Extent of CAD 385 , 0.001 2.8 (2.5–3.1) 267 , 0.001 2.5 (2.3–2.8)
SRS† (1-point increase) 207 , 0.001 1.13 (1.11–1.15) 57 , 0.001 1.07 (1.06–1.09)
SSS‡ (5-point decrease) 186 , 0.001 1.5 (1.4–1.6) — — —
Chest pain class 114 , 0.001 1.5 (1.4–1.7) 62 , 0.001 1.4 (1.3–1.6)
Age (10-year increase) 54 , 0.001 1.4 (1.3–1.5) — — —
Symptom status 49 , 0.001 2.3 (1.8–2.9) — — —
Hyperlipidemia 14 , 0.001 1.4 (1.2–1.7) — — —
Cardiac enlargement 9 0.003 1.4 (1.1–2.6) — — —
Gender (male) 7 0.010 1.3 (1.1–1.6) — — —
Pharmacologic stress 7 0.010 0.8 (0.6–0.9) 6 0.014 0.7 (0.6–0.9)
Hypertension 6 0.02 1.2 (1.0–1.5) — — —
Smoking 1 NS 1.1 (0.9–1.2) — — —
Diabetes , 1 NS 0.9 (0.8–1.1) — — —
*Variables without numbers in the multivariate analysis did not meet the entry criteria into the final model; †a summed reversibility score (SRS) of 0 represents a nonischemic
image; ‡a summed stress score (SSS) of 56 represents a normal image. Final model: chi-square 5 652, p , 0.001; C-index 5 0.82. Bootstrapping analysis the extent of CAD
came into every model, SRS and chest pain class in 98% of the models and pharmacologic stress in 64%. In the initial multivariate stepwise analysis, symptom status just met
the entry criteria into the model (chi-square 5 4, p 5 0.038). In the bootstrapping analysis, it came into only 13% of the models. This variable was therefore eliminated from
the final multivariate model.
CAD 5 coronary artery disease; other abbreviations as in Table 3.
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